Quantification of poly(I:C)-mediated protection against genital herpes simplex virus type 2 infection.
about
HSV-2: in pursuit of a vaccineTLR9 and RIG-I signaling in human endocervical epithelial cells modulates inflammatory responses of macrophages and dendritic cells in vitroToll-Like Receptors and Viruses: Induction of Innate Antiviral Immune ResponsesDampened antiviral immunity to intravaginal exposure to RNA viral pathogens allows enhanced viral replicationInduction of interferon-λ contributes to TLR3 and RIG-I activation-mediated inhibition of herpes simplex virus type 2 replication in human cervical epithelial cells.Toll-like receptor 3 signaling on macrophages is required for survival following coxsackievirus B4 infection.Mucosal treatments for herpes simplex virus: insights on targeted immunoprophylaxis and therapyToll-like receptor 3 agonist protection against experimental Francisella tularensis respiratory tract infectionImmunobiology of herpes simplex virus and cytomegalovirus infections of the fetus and newbornThe murine intravaginal HSV-2 challenge model for investigation of DNA vaccines.Commensal bacteria modulate innate immune responses of vaginal epithelial cell multilayer culturesInnate and adaptive immune responses to herpes simplex virusTLR3 signaling is either protective or pathogenic for the development of Theiler's virus-induced demyelinating disease depending on the time of viral infectionChlamydial Pre-Infection Protects from Subsequent Herpes Simplex Virus-2 Challenge in a Murine Vaginal Super-Infection Model.Sensing of viral infection and activation of innate immunity by toll-like receptor 3Intravaginal TLR agonists increase local vaccine-specific CD8 T cells and human papillomavirus-associated genital-tumor regression in miceLearning from the messengers: innate sensing of viruses and cytokine regulation of immunity - clues for treatments and vaccines.Toll-like receptor signaling in HIV-1 infection: a potential target for therapy?Toll-like receptors in the gonads and reproductive tract: emerging roles in reproductive physiology and pathology.IL-36γ Augments Host Defense and Immune Responses in Human Female Reproductive Tract Epithelial Cells.Double-stranded RNA analog poly(I:C) inhibits human immunodeficiency virus amplification in dendritic cells via type I interferon-mediated activation of APOBEC3G.Salmonella enterica serovar typhimurium exploits Toll-like receptor signaling during the host-pathogen interaction.FSL-1, a bacterial-derived toll-like receptor 2/6 agonist, enhances resistance to experimental HSV-2 infection.TLR3 activation efficiency by high or low molecular mass poly I:C.Toll-like receptors and genital tract infection.Induction of innate immune responses in the female genital tract: friend or foe of HIV-1 infection?Sensing herpes: more than toll.Prophylactic and therapeutic implications of toll-like receptor ligands.Type I interferons in regulation of mucosal immunity.Antitumor activity from the combined application of poly(I:C) and chemotherapeutics in human metastatic pharyngeal cell lines.Development and characterization of a three-dimensional organotypic human vaginal epithelial cell model.Long-lasting antiviral innate immune priming in the Lophotrochozoan Pacific oyster, Crassostrea gigas.Toll-like receptor 3 pathway restricts Marek's disease virus infection.Effect of pretreatment with toll-like receptor agonists in a mouse model of herpes simplex virus type 1 encephalitis.A minimal RNA ligand for potent RIG-I activation in living mice.
P2860
Q22306291-EDA76527-9538-4B94-939D-9B64F9B6CBE1Q24318849-DBF1F543-B062-4EA7-B07F-ACD674635AB1Q27487393-D122BDA2-7ECC-4BC2-9465-EE6B702D1CD8Q27869764-4B38B63D-540E-40E7-BC22-9682F71916DCQ30683907-4EAF2ADF-996E-4C29-8A9B-94E29CDB986DQ33397372-1DCACA15-114B-4444-B676-FA5680A581C3Q33710019-F7FA03DB-1C35-4707-B673-FEBCB4363A30Q33768930-3763C358-2227-4F92-9224-7822DF246978Q33835386-4A4A68B4-A380-4993-B3C5-02FBC07BC2C9Q33856067-F39BAE72-7DDF-4CC6-8CDE-E9EB067D25D6Q34193360-E7AA1320-BE65-49E9-859F-52908096E7ACQ35260078-B66A940B-CF8A-4476-A9CE-0970FD9E0823Q35800442-AE5C3694-4E2F-4851-868E-29DC95652C1EQ35883842-2DFA1AAB-5F24-4B9D-8E1E-34E7948E8648Q36422519-F44668EA-F102-4765-92C9-74463FB06277Q36612204-2DE3D227-1311-41D7-A45C-8E5C0D010F42Q36807121-22CF6DC9-0844-4E07-A6E9-5319E3B9070EQ36839684-BE414A6F-4AA9-483A-A250-FF810C095F24Q36860597-CF67C25A-60DE-4C93-9E0C-2C17F7B96F27Q37014472-5C7E35A5-15C7-45F0-A5E6-98235730910CQ37033387-7F67ED73-A11A-4B24-82F1-4A09FB5C98A0Q37410335-BFB9C93B-EE60-4F65-AAF1-A5E22A743D13Q37428262-ED879AF4-DDAA-4166-9363-D7DD63B8E9D6Q37616611-6B77F560-5CF9-4843-8F42-BD0ACF8B1286Q37705702-E872B2A4-C40B-4E48-AF96-97225EDB0438Q37827571-9FA07428-C089-495F-BFD4-1E27D31FC7CFQ37948677-2AE908ED-5393-4801-89A4-0AD08B29FFC7Q37989884-DCE1A17D-9686-4A5C-B2F7-5A7D40FDB9C8Q37994985-F66C0FEA-8A33-4209-A5FE-951739A98A07Q39424521-D02AC4A1-6A86-49C1-86AF-66DFF49AB05EQ39763796-E5B6F388-95B5-436B-B36F-2611CD6F3F2BQ42377146-17991E5B-30CA-42F3-B474-4FE0D3989C07Q42378485-F14FEBB0-A94F-49D1-B9BE-E29CCFA50047Q45392569-6D95AF29-4766-4DAD-A480-F18F9C734EEFQ50335102-1FAA796A-0452-402C-AFD2-051965A68394
P2860
Quantification of poly(I:C)-mediated protection against genital herpes simplex virus type 2 infection.
description
2006 nî lūn-bûn
@nan
2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Quantification of poly(I:C)-me ...... implex virus type 2 infection.
@ast
Quantification of poly(I:C)-me ...... implex virus type 2 infection.
@en
type
label
Quantification of poly(I:C)-me ...... implex virus type 2 infection.
@ast
Quantification of poly(I:C)-me ...... implex virus type 2 infection.
@en
prefLabel
Quantification of poly(I:C)-me ...... implex virus type 2 infection.
@ast
Quantification of poly(I:C)-me ...... implex virus type 2 infection.
@en
P2860
P356
P1433
P1476
Quantification of poly(I:C)-me ...... simplex virus type 2 infection
@en
P2093
Richard B Pyles
P2860
P304
P356
10.1128/JVI.01099-06
P407
P577
2006-10-01T00:00:00Z